Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
CA LÂM SÀNG Issue: Số 104 năm 2023 BỆNH MẠCH VÀNH

Article

Nguyễn Ngọc Quang: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai; Lê Xuân Thận: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai;
Published: March 31, 2023
Views: 176
DOI 10.58354/jvc.104.2023.297
No abstract or full text is available for this article.

References

1.
Epstein E., Goedel A. Hamorrhagische Thrombozytamie bei vaskularer Schrumpfmils. Virchows Arch Pathol Anat. 1934;292:233-248.
2.
Silverstein MN. Primary or hemorrhagic thrombocythemia. Arch Intern Med. 1968;122:18-22.
3.
Raabe WA et al. ESSENTIAL THROMBOCYTHAEMIA. The Lancet. Published online 198AD:1021.
4.
Bellucci S, Janvier M, Tobelem G, et al. Essential thrombocythemias. Clinical evolutionary and biological data. Cancer. 1986;58(11):2440-2447.
5.
Barbui T, Vannucchi AM, Buxhofer-Ausch V, et al. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer Journal. 2015;5(11):e369-e369.
6.
Virmani R. et al. Thrombocytosis, coronary thrombosis and acute myocardial infarction. Am J Med. 1979;67:498-505.
7.
Scheffer MG et al. Thrombocythemia and coronary artery disease. Am Heart J. 122(573-576):1991.
8.
Rossi C, RandI ML, Zerbinati P, Rinaldi V, Girolami A. Acute coronary disease in essential thrombocythemia and polycythemia vera. Journal of Internal Medicine. 1998;243(7):49-53.
9.
Vianello F, Cella G, Osto E, et al. Coronary microvascular dysfunction due to essential thrombocythemia and policythemia vera: The missing piece in the puzzle of their increased cardiovascular risk?: Coronary Flow Reserve in Myeloproliferative Neoplasms. Am J Hematol. 2015;90(2):109-113
10.
Vrtovec M, Anzic A, Zupan IP, Zaletel K, Blinc A. Carotid artery stiffness, digital endothelial function, and coronary calcium in patients with essential thrombocytosis, free of overt atherosclerotic disease. Radiology and Oncology. 2017;51(2):203-210.
11.
Anžič Drofenik A, Vrtovec M, Božič Mijovski M, et al. Progression of coronary calcium burden and carotid stiffness in patients with essential thrombocythemia associated with JAK2 V617F mutation. Atherosclerosis. 2020;296:25-31.
12.
for the Study Alliance Leukemia (SAL), Kaifie A, Kirschner M, et al. Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry. J Hematol Oncol. 2016;9(1):18.
13.
Carobbio A, Thiele J, Passamonti F, et al. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood. 2011;117(22):5857-5859.
14.
T. Momiyama et al. Coronary artery bypass grafting for left main trunk coronary artery lesion associated with essential thrombocythemia - PubMed. Clin Cardiol. 1993;16(9):691-693.
15.
H. Kaya. Essential thrombocythemia and recurrent myocardial infarction - PubMed. Clin Lab Haematol. 2000;22(3):161-162.
16.
R. A. Pick et al. Acute myocardial infarction with essential thrombocythemia in a young man - PubMed. Am Heart J. 1983;106(2):406-407.
17.
Y. Hamada. Multiple coronary thrombosis in a patient with thrombocytosis - PubMed. Clin Cardiol. 1989;12(12):723-724.
18.
A. D. Michaels et al. Multivessel coronary thrombosis treated with abciximab (ReoPro) in a patient with essential thrombocythemia - PubMed. Clin Cardiol. 1998;21(2):134-138.
19.
J. E. Saffitz. Thrombocytosis and fatal coronary heart disease - PubMed. Am J Cardiol. 1983;52(5):651-652.
20.
Shoichi Kuramitsu et al. Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis - PubMed. Circ Cardiovasc Interv. 2019;12(6):e007822.
21.
Dirk Sibbing et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis - PubMed. J Am Coll Cardiol. 2009;53(10):849-856.
22.
Kuliczkowski W, Żurawska-Płaksej E, Podolak-Dawidziak M, et al. Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders. Severino P, ed. Cardiology Research and Practice. 2021;2021:1-7. d
23.
Shlomi Matetzky et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction - PubMed. Circulation. 2004;109(25):171-175.
24.
Stavros Spiliopoulos et al. Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: the PRECLOP study: clinical impact and optimal cutoff value of on-treatment high platelet reactivity - PubMed. J Am Coll Cardiol. 2013;61(24):2428-2434.
25.
Paul A. et al. Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target - PubMed. Platetets. 2008;19(8):595-604.
26.
Paul A. et al. Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents - PubMed. Circulation. 2012;125(10):1276-1287.
27.
Somjot S. et al. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data - PubMed. J Am Coll Cardiol. 2011;58(19):1945-1954.
28.
Alexopoulos D, Xanthopoulou I, Gkizas V, et al. Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction. Circ: Cardiovascular Interventions. 2012;5(6):797-804.
29.
Bliden KP, Tantry US, Storey RF, et al. The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: Combined analysis of the ONSET/OFFSET and RESPOND studies. American Heart Journal. 2011;162(1):160-165.
30.
Orme RC, Parker WAE, Thomas MR, et al. Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease. Circulation. 2018;138(13):1290-1300.

Files

Article Views176
Document Views0
Downloads0
Section CA LÂM SÀNG
Issue Số 104 năm 2023
Category BỆNH MẠCH VÀNH

Related articles section label

Related articles

Related articles category hint

More articles

NT-proBNP reflects myocardial injury phenotype in acute coronary syndromes: A cross-sectional study in a predominantly unstable angina population

Objective: To evaluate the value of NT-proBNP in relation to myocardial injury markers and the extent of coronary artery disease, thereby clarifying its role according to myocardial injury phenotype in acute coronary syn...

Chi tiết bài báo
PDF
DOI: 10.58354/jvc.120.2026.1306
89
Đoàn Ngọc Anh; Nguyễn Quốc Khoa; Dương Thị Thu Hằng; Võ Lương Tài; Trương Thị Huyền; Đặng Thế Việt; Võ Phạm Minh Thư; Đặng Thị Phương Thảo

Study of left ventricular function using tissue-tracking echocardiography in patients with chronic coronary syndrome without indications for coronary revascularization

Objectives: To evaluate the index of global left ventricular longitudinal strain (GLS) and its relationship with some clinical and paraclinical parameters in patients with chronic coronary artery syndrome without indicat...

Chi tiết bài báo
DOI: 10.58354/jvc.111.2024.866
114
Mai Thị Thương; Nguyễn Văn Thành; Đỗ Doãn Lợi